Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort  Shelley.

Similar presentations


Presentation on theme: "Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort  Shelley."— Presentation transcript:

1 Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort  Shelley Ji Eun Hwang, MBBS (Hons), Giuliana Carlos, MBBS, Deepal Wakade, MD, Karen Byth, PhD, Benjamin Y. Kong, MBBS, Shaun Chou, MBBS, Matteo S. Carlino, MBBS, FRACP, Richard Kefford, MBBS, PhD, FRACP, Pablo Fernandez-Penas, MD, PhD, FACD  Journal of the American Academy of Dermatology  Volume 74, Issue 3, Pages e1 (March 2016) DOI: /j.jaad Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Estimated cumulative incidence of developing the first lichenoid reactions (A), eczema (B), and vitiligo (C) by months since commencement of treatment. Tick marks represent censored observations. Journal of the American Academy of Dermatology  , e1DOI: ( /j.jaad ) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort  Shelley."

Similar presentations


Ads by Google